Compare top Myeloma doctors and prices in Israel. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
18
Israel
Reviews
14,000+
From real patients
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Show first:
Professor Ron Ram practices at Sourasky Medical Center (Ichilov), Israel's largest university hospital.
Dr. El Hasid has conducted over 300 bone marrow and cord blood transplants for children. She leads the Pediatric Oncohematology and Oncology Department at Dana Dwek Children's Hospital.
Dr. Ron Ram has performed several hundred stem cell transplants at Sourasky Medical Center – a key procedure for treating Myeloma.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Dr. Michael Shapira is a senior hematologist known for proving age is no barrier to successful stem cell transplants. He leads the Hematology Inpatient Unit and Day Hospital at Tel Aviv Sourasky Medical Center.
Dr. Dror Levin is a leading expert in pediatric blood disorders and bone cancer, directing the children's hematology oncology department at Sourasky Medical Center.
Dr. Fredi Aviv has focused on Myeloma for 34 years of experience at Tel Aviv's major Sourasky Medical Center.
Dr. Kirshner is actively involved in myeloma research and clinical trials, including phase III trials testing new treatment combinations.
Dr. Yair is an award-winning hematologist at Sourasky Medical Center, specializing in blood cancers like myeloma.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Professor Ben-Yehuda is Head of Hematology at Hadassah Medical Center and a recognized Dean of its Medical School.
Oncohematologist Ofer Spielberg treats blood cancers at Assuta Medical Center.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
142 patients from Israel have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | 24 years of experience | Myeloma requiring bone marrow transplant | Practices within a premier unit led by Israel's top hemato-oncologists, specializing in transplants and advanced cellular immunotherapy. Colleagues are published international experts. | Israel | Price on request
| |
| #2 | 38 years of experience | Pediatric bone marrow transplants | Over 300 transplant procedures performed – focuses solely on pediatric transplants. Head of the department and member of leading hematology societies. | Israel | Price on request
| |
| #3 | 24 years of experience | Myeloma requiring stem cell transplant | Performs hundreds of stem cell transplants for Myeloma. Combines transplant experience with deep academic expertise, having published over 30 scientific articles. | Israel | Price on request
| |
| #4 | 36 years of experience | Older adult myeloma patients | Pioneer in proving age is no barrier to transplants—successfully treating patients over 70. Senior director at a major academic hospital and recognized for his groundbreaking work. | Israel | Price on request
| |
| #5 | 41 years of experience | Pediatric bone cancer (sarcoma) | Directs pediatric hematology oncology at Sourasky Medical Center. Trained at Italy's Rizzoli Orthopaedic Institute – a global leader in bone oncology. | Israel | Price on request
| |
| #6 | 34 years of experience | Myeloma and complex blood cancers | Oncohematologist with three decades of focused experience at a top-tier medical center, specializing in blood cancer treatment protocols. | Israel | Price on request
| |
| #7 | 32 years of experience | Advanced treatment approaches | Active in developing new myeloma treatments through clinical trials. Fellowship-trained at Montefiore, with dual specialization in hematology and oncology. | Israel | Price on request
| |
| #8 | 24 years of experience | Chronic lymphocytic leukemia | Recognized with multiple awards for hematology research. Member of key professional associations. Specializes in blood cancers with extensive training. | Israel | Price on request
| |
| #9 | 34 years of experience | Complex myeloma & bone marrow transplant | Led the hematology department for over 20 years and pioneered gene therapy research. Dean of Hadassah Medical School and recipient of the Healing with the Heart Award. | Israel | Price on request
| |
| #10 | Myeloma treatment | Specializes exclusively in myeloma and blood cancers, treating patients at a leading private hospital network in Israel. | Israel | Price on request
|
Leading myeloma specialists in Israel include Dr. Hila Magen and Dr. Abraham Avigdor at Sheba Medical Center, and Dr. Ron Ram at Sourasky Medical Center. These experts emphasize advanced cellular therapies like CAR-T and complex stem cell transplantation to treat relapsed or high-risk cases.
Bookimed Expert Insight: While many specialists treat blood cancers, choosing a director of a specific myeloma or transplant unit often provides faster access to clinical trials. For example, Dr. Hila Magen acts as a principal investigator for innovative CAR-T programs, which can offer treatment paths not available at smaller oncology centers.
Patient Consensus: Patients often feel more secure in major units like those at Sheba or Sourasky because the departments work as a cohesive team. Experience bears out that having a specialist who can quickly determine transplant eligibility makes a significant difference in the treatment journey.
Israeli specialists are global leaders in multiple myeloma treatment, performing hundreds of stem cell transplants and pioneering CAR T-cell therapy. Experts like Dr. Abraham Avigdor and Dr. Hila Magen lead dedicated units focused on these intensive cellular immunotherapies at JCI-accredited centers.
Bookimed Expert Insight: Israeli centers like Sheba and Sourasky operate dedicated Multiple Myeloma and Amyloidosis units. These units are led by specialists with 30+ years of experience who have published over 250 research papers. This high academic volume allows patients access to point-of-care CAR-T programs that are often unavailable elsewhere.
Patient Consensus: Patients receiving treatment for myeloma say they appreciate the deeply personal approach to complex transplant care. Many mention feeling safer knowing their doctors trained at top US centers like Memorial Sloan-Kettering or Johns Hopkins.
Myeloma specialists in Israel are highly experienced, with leaders like Dr. Fredi Aviv at Sourasky Medical Center holding 30+ years of practice. Many are board-certified in hematology and oncology, having completed fellowships at major centers like Montefiore Medical Center or City of Hope.
Bookimed Expert Insight: Data shows Israeli hematologists often hold dual or triple board certifications in internal medicine, hematology, and oncology. This broad expertise at centers like Sourasky Medical Center (Ichilov) allows them to manage complex myeloma cases where the disease affects multiple organ systems simultaneously.
Patient Consensus: Patients often feel relieved to work with specialists who have spent decades focusing specifically on blood cancers. They appreciate that doctors at large centers like Sourasky provide individual transplant plans and use the latest cellular therapies.
International patients can contact myeloma specialists in Israel through Bookimed to arrange consultations at top hospitals. Specialists like Dr. Ron Ram at Sourasky Medical Center (Ichilov) and Professor Dina Ben-yehuda at Hadassah Medical Center provide advanced hematology care, second opinions, and stem cell transplant evaluations.
Bookimed Expert Insight: While many Israeli myeloma specialists work in large public university hospitals, some also practice at private centers like Assuta Medical Center. Dr. Ofer Spielberg exclusively focuses on myeloma and blood cancers at Assuta, which often provides faster access to consultations for international patients compared to the potentially longer wait times at major government facilities.
Patient Consensus: Patients suggest attaching recent reports immediately rather than waiting for a request to avoid delays. Being organized and responsive makes the process easier since international coordination feels more like case management than a standard clinic visit.